series-b
Stage
2026
Founded
1
Investors
About
Comanche Biopharma is developing an investigational siRNA therapy aimed at preventing or treating preterm preeclampsia, a life-threatening pregnancy complication.
Explore Comanche Biopharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.